The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings

Salvatore Amoroso, Elodia Iannotti, Maria Luigia Saggese, Gianfranco Di Renzo, Lucio Annunziato

Research output: Contribution to journalArticlepeer-review

Abstract

In this study the effect of the A1 agonist 2-chloro-N6-cyclopentyladenosine (CCPA) on bis(1,3-diethylthiobarbituric acid) trimethine oxonol (bisoxonol)-monitored membrane potential in cerebrocortical nerve endings was evaluated. CCPA (30, 100 and 300 μM) caused a dose-dependent decrease of high K+- and veratridine-induced membrane depolarization. This decrease was counteracted by the A1-specific antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (30-100 μM). On the contrary, the A2 receptor antagonist 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolol-[1,5-c]quinazoline-5-imine (CGS 15943) was unable to interface with the lowering effect exerted by CCPA (100 μM) on K+-elicited membrane depolarization. Finally, the A2 receptor agonist 2-[p-(2-carboxyl-ethyl)phenethylamine]-5′-N-ethylcarboxamidoadenosine (CGS 21680) did not induce any modification of K+-induced membrane depolarization. The results of the present study suggest that K+-induced membrane depolarization in cerebrocortical brain nerve endings may be modulated by A1 receptors.

Original languageEnglish
Pages (from-to)67-73
Number of pages7
JournalBBA - Biomembranes
Volume1239
Issue number1
DOIs
Publication statusPublished - Oct 4 1995

Keywords

  • A-agonist activity
  • Agonist
  • Bisoxonol monitoring
  • Cerebrocortical nerve ending
  • Chlorocyclopentyladenosine
  • Membrane potential
  • Potassium ion

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology

Fingerprint

Dive into the research topics of 'The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings'. Together they form a unique fingerprint.

Cite this